Drug Eye Africa

Egypt's EDA recalls batch of EPOETIN 4000 IU vial over commercial fraud

The Egyptian Drug Authority (EDA) has recalled batch EPOETIN-0326601 following detection of commercial fraud.

The alert applies exclusively to the batch named in the notice and does not extend to general distribution of the product. The company manufacturing the product, as stated on the packs, is Sedico for pharmaceutical industries.

Circulation of packs of unknown source of the item shown above. This is based on what was received from Sedico for pharmaceutical industries, that the packs with the shown differences do not belong to them and were not produced or manufactured with their knowledge. The packs of unknown source can be distinguished as shown in the link.

Sources

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top